differential pricing

Authors from MSF and Harvard School of Public Health have published a critical analysis of the role of tiered pricing to improve access to medicines in developing countries. The study was presented...

In Medical Journals / Research Articles – Last updated 15 November 2011
www.msfaccess.org/content/win-win-solution-critical-analysis-tiered-pricing-improve-access-medicines-developing

Each year, MSF publishes a survey of the latest prices for antiretroviral medicines to treat people living with HIV/AIDS in developing countries. It started out as a way of offering a practical guide...

Web article – Last updated 08 August 2011
www.msfaccess.org/content/caught-middle-%E2%80%93-hiv-medicines-pricing-sky-high-%E2%80%98middle-income%E2%80%99-countries

Company price discounts The pharmaceutical industry’s preferred response to the crisis in access to medicines is to establish price discount programmes to combat specific diseases where they offer...

Static page – Last updated 09 August 2011
www.msfaccess.org/content/overcoming-patent-barriers-through-voluntary-measures

Las vacunas son responsables de algunos de los mayores hitos de la salud pública del siglo pasado.  Se calcula que la inmunización ayuda a prevenir la muerte de cerca de 2,5 millones...

Report – Last updated 10 May 2010
www.msfaccess.org/content/la-mejor-inyecci%C3%B3n-para-los-pa%C3%ADses-en-v%C3%ADas-de-desarrollo-panorama-del-acceso-y-la-id-de

The Access Campaign first published a report on AIDS drug prices in 2001, in response to the lack of transparent information available for treatment providers to be able to make informed purchasing...

Report – Last updated 21 January 2010
www.msfaccess.org/content/untangling-web-antiretroviral-price-reductions-12th-edition-january-2010

 Vaccines have made possible some of the greatest public health successes in the past century. Immunisation helps avert an estimated 2.5 million child deaths each year, as well as millions...

Report – Last updated 10 May 2010
www.msfaccess.org/content/giving-developing-countries-best-shot-overview-vaccine-access-and-rd

The 12th edition of ‘Untangling the Web’, Médecins Sans Frontières’ annual analysis of antiretroviral (ARV) price reductions is upcoming. This paper serves as a pre-publication...

Report – Last updated 18 July 2009
www.msfaccess.org/content/untangling-web-antiretroviral-price-reductions-upcoming-12th-edition-pre-publication-price

This is the sixth edition of 'Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries'. The first edition was published in October 2001. The...

Report – Last updated 01 April 2004
www.msfaccess.org/content/untangling-web-6th-edition-english-version

This is the seventh edition of Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries. The report was first published by MSF in October 200, in response...

Report – Last updated 01 January 2005
www.msfaccess.org/content/untangling-web-7th-edition-english-version

This is the eighth edition of Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries. The report was first published by Médecins Sans Frontières...

Report – Last updated 05 September 2006
www.msfaccess.org/content/untangling-web-8th-edition-portuguese-version